@article{41676,
      note = {This resource was extracted from the Directory of Open  Access Books (DOAB)},
      author = {Nonaka, Hirotaka},
      url = {http://tind.wipo.int/record/41676},
      title = {FTO (Freedom to Operate) in the Pharmaceutical Industry /},
      abstract = {FTO licensing in the pharmaceutical industry deserves  special consideration because of the large economic scale  of the market, expensive cost of R&D, extremely low success  rate, and easy duplication of the drug. Taking these unique  aspects into consideration, the author first explaines how  to perform a good FTO search and conclude an appropriate  FTO licensing agreement, and then points out two issues;  (i) the issue of FTO licensing and EU competition,  especially the unreasonable application of the Guideline,  and (ii) the issue of FTO licensing and differentiating  between a bio venture company and a pharmaceutical company.  Solutions for these issues are proposed.},
      doi = {http://dx.doi.org/10.5771/9783845294018},
      recid = {41676},
      pages = {63 pages},
}